Oral management strategies for radiotherapy of head and neck cancer

被引:60
作者
Kawashita, Yumiko [1 ]
Soutome, Sakiko [1 ]
Umeda, Masahiro [2 ]
Saito, Toshiyuki [3 ]
机构
[1] Nagasaki Univ Hosp, Dept Oral Management Ctr, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528102, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Hlth, Nagasaki, Japan
关键词
Head and neck cancer; Radiotherapy; Oral management; CLINICAL-PRACTICE GUIDELINES; MODULATED RADIATION-THERAPY; DENTAL-CARIES; OSTEORADIONECROSIS; MUCOSITIS; PREVENTION; OSTEONECROSIS; JAW; CHEMORADIOTHERAPY; POSTIRRADIATION;
D O I
10.1016/j.jdsr.2020.02.001
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Radiotherapy, often with concomitant chemotherapy, has a significant role in the management of head and neck cancer, however, radiotherapy induces adverse events include oral mucositis, hyposalivation, loss of taste, dental caries, osteoradionecrosis, and trismus, all of which have an impact on patients' quality of life. Therefore, it is necessary to implement oral management strategies prior to the initiation of radiotherapy in patients with head and neck cancer. Since 2014, the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) have enumerated the "Principles of Dental Evaluation and Management (DENT-A)" in the section on head and neck cancers, however, oral management was not explained in detail. Oral management has not been achieved a consensus protocol. The aim of this literature is to show that oral management strategy include removal infected teeth before the start of radiotherapy to prevent osteoradionecrosis, oral care for preventing severe oral mucositis to support patient complete radiotherapy during radiotherapy, and prevent of dental caries followed by osteoradionecrosis after radiotherapy. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of The Japanese Association for Dental Science.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 70 条
[61]   Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis [J].
Rubenstein, EB ;
Peterson, DE ;
Schubert, M ;
Keefe, D ;
McGuire, D ;
Epstein, J ;
Elting, LS ;
Fox, PC ;
Cooksley, C ;
Sonis, ST .
CANCER, 2004, 100 (09) :2026-2046
[62]   Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial [J].
Rugo, Hope S. ;
Seneviratne, Lasika ;
Beck, J. Thaddeus ;
Glaspy, John A. ;
Peguero, Julio A. ;
Pluard, Timothy J. ;
Dhillon, Navneet ;
Hwang, Leon Christopher ;
Nangia, Chaitali ;
Mayer, Ingrid A. ;
Meiller, Timothy F. ;
Chambers, Mark S. ;
Sweetman, Robert W. ;
Sabo, J. Randy ;
Litton, Jennifer K. .
LANCET ONCOLOGY, 2017, 18 (05) :654-662
[63]   Recent advances in oral oncology 2008; squamous cell carcinoma imaging, treatment, prognostication and treatment outcomes [J].
Scully, Crispian ;
Bagan, Jose V. .
ORAL ONCOLOGY, 2009, 45 (06) :E25-E30
[64]   Perspectives on cancer therapy-induced mucosal injury - Pathogenesis, measurement, epidemiology, and consequences for patients [J].
Sonis, ST ;
Elting, LS ;
Keefe, D ;
Peterson, DE ;
Schubert, M ;
Hauer-Jensen, M ;
Bekele, BN ;
Raber-Durlacher, J ;
Donnelly, JP ;
Rubenstein, EB .
CANCER, 2004, 100 (09) :1995-2025
[65]  
Sonis Stephen T, 2004, J Support Oncol, V2, P21
[66]   Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis [J].
Sroussi, Herve Y. ;
Epstein, Joel B. ;
Bensadoun, Rene-Jean ;
Saunders, Deborah P. ;
Lalla, Rajesh V. ;
Migliorati, Cesar A. ;
Heaivilin, Natalie ;
Zumsteg, Zachary S. .
CANCER MEDICINE, 2017, 6 (12) :2918-2931
[67]   Prevention and treatment of the consequences of head and neck radiotherapy [J].
Vissink, A ;
Burlage, FR ;
Spijkervet, FKL ;
Jansma, J ;
Coppes, RP .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2003, 14 (03) :213-225
[68]   Oral complications of targeted cancer therapies: A narrative literature review [J].
Watters, A. L. ;
Epstein, J. B. ;
Agulnik, M. .
ORAL ONCOLOGY, 2011, 47 (06) :441-448
[69]   Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy [J].
Yokota, Tomoya ;
Tachibana, Hiroyuki ;
Konishi, Tetsuhito ;
Yurikusa, Takashi ;
Hamauchi, Satoshi ;
Sakai, Kensuke ;
Nishikawa, Masaya ;
Suzuki, Miho ;
Naganawa, Yayoi ;
Hagihara, Tomoka ;
Tsumaki, Hiromi ;
Kubo, Tomo ;
Sato, Maho ;
Taguri, Masataka ;
Morita, Satoshi ;
Eguchi, Toru ;
Kubota, Kaoru ;
Zenda, Sadamoto .
SUPPORTIVE CARE IN CANCER, 2016, 24 (07) :3029-3036
[70]   Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations [J].
Zecha, Judith A. E. M. ;
Raber-Durlacher, Judith E. ;
Nair, Raj G. ;
Epstein, Joel B. ;
Sonis, Stephen T. ;
Elad, Sharon ;
Hamblin, Michael R. ;
Barasch, Andrei ;
Migliorati, Cesar A. ;
Milstein, Dan M. J. ;
Genot, Marie-Therese ;
Lansaat, Liset ;
van der Brink, Ron ;
Arnabat-Dominguez, Josep ;
van der Molen, Lisette ;
Jacobi, Irene ;
van Diessen, Judi ;
de lange, Jan ;
Smeele, Ludi E. ;
Schubert, Mark M. ;
Bensadoun, Rene-Jean .
SUPPORTIVE CARE IN CANCER, 2016, 24 (06) :2781-2792